unwant
substanc
excess
fluid
pulmonari
edema
lung
parenchyma
unlik
pleural
space
exist
sole
purpos
studi
pleurodesi
iatrogen
obliter
pleural
space
prevent
recurr
effus
pneumothorac
show
signific
limit
pulmonari
function
patient
receiv
talc
pleurodesi
year
ago
spontan
pneumothorac
show
higher
incid
pleural
thicken
minim
restrict
chang
lung
function
sever
small
studi
human
anim
also
reveal
signific
impair
lung
volum
gaseou
exchang
rest
exercis
follow
pleurodesi
fact
obliter
pleural
space
affect
health
function
support
belief
pleural
space
human
serv
signific
role
pleural
space
exist
first
place
preserv
evolut
remain
unansw
type
pneumonia
alway
includ
common
communityacquir
pathogen
spectrum
broaden
respons
either
increas
immunocompromis
greater
exposur
broadspectrum
antibiot
new
previous
unrecogn
pathogen
play
role
manag
decis
major
issu
pneumonia
appear
antibiot
resist
strain
known
common
bacteri
pathogen
lack
even
minim
effect
agent
issu
nonbacteri
pneumonia
immunomodul
form
less
immunosuppress
cancer
transplant
chemotherapi
immun
specif
immunomodulatori
drug
hold
hope
improv
pneumonia
outcom
futur
pneumonia
infect
distal
lower
respiratori
tract
princip
alveolar
space
includ
small
bronchi
bronchiol
pneumonia
result
prolifer
microorgan
site
combin
host
respons
presenc
microorgan
prolifer
alon
necessarili
result
pneumonia
sinc
mani
patient
chronic
mechan
ventil
quantit
coloni
count
thought
diagnost
pneumonia
set
without
clinic
manifest
pneumonia
presenc
microorgan
without
correspond
host
immun
reaction
design
colon
infect
alveolar
level
distinguish
pneumonia
respiratori
tract
infect
may
confus
clinic
infect
conduct
airway
vocal
cord
design
tracheiti
bronchiti
bronchiol
depend
main
area
involv
time
combin
lower
respiratori
tract
infect
lrti
distinguish
upper
respiratori
infect
uri
latter
includ
laryng
pharyng
rhiniti
gener
common
often
viral
gener
less
seriou
diphtheria
acut
epiglott
pertussi
except
gener
rule
suggest
care
distinct
accur
diagnosi
critic
clinic
care
even
within
design
pneumonia
varieti
pneumonia
syndrom
occur
tabl
classifi
number
way
base
microbi
etiolog
underli
host
defens
clinic
present
among
other
common
initi
group
patient
locat
time
acquisit
communityacquir
nosocomi
pneumonia
recent
third
categori
ad
healthcareassoci
pneumonia
hcap
tabl
categori
need
design
patient
pneumonia
develop
outsid
hospit
whose
pathogenesi
caus
agent
antibiot
resist
pattern
consist
nosocomi
pathogen
major
patient
nurs
home
group
also
includ
chronic
dialysi
patient
other
frequent
recent
contact
medic
system
within
categori
patient
compromis
immun
usual
discuss
separ
sinc
spectrum
caus
etiolog
much
larger
therefor
diagnost
therapeut
approach
differ
patient
overtli
normal
host
immun
pneumonia
syndrom
separ
entri
encyclopedia
common
compon
patholog
pneumonia
inflammatori
respons
within
lung
parenchyma
pattern
inflammatori
respons
vari
caus
etiolog
mycobacteri
fungal
infect
result
granulomat
respons
character
histiocyt
mononuclear
cell
prolifer
bacteri
pneumonia
result
neutrophil
alveol
mani
virus
oblig
intracellular
agent
gener
lymphocyt
alveol
key
develop
pattern
pneumonia
alveolar
macrophag
overwhelm
major
microorgan
reach
alveolar
level
kill
andor
clear
alveolar
macrophag
without
induc
inflammatori
respons
simpli
get
alveolar
level
mean
microorgan
avoid
mechan
host
defens
mechan
upper
respiratori
tract
conduct
airway
includ
branch
airway
pattern
mucociliari
clearanc
mechan
mucos
immunoglobulin
complement
surfact
lactoferrin
defensin
antimicrobi
peptid
given
microbi
particl
challeng
present
respiratori
tract
daili
basi
mechan
highli
effici
prevent
overwhelm
challeng
alveolar
macrophag
howev
either
virul
volum
microorgan
expos
alveolar
macrophag
overwhelm
respons
releas
varieti
mediat
elicit
inflammatori
respons
appropri
particular
challeng
inflammatori
respons
rather
shear
number
microorgan
respons
radiograph
chang
pneumonia
mediat
releas
part
inflammatori
respons
result
mani
clinic
manifest
fever
leukocytosi
microorgan
reach
alveolar
level
two
major
mechan
aerosol
deposit
aspir
infect
bolu
former
mechan
viral
mycobacteri
fungal
infect
mani
bacteri
pneumonia
result
aspir
aspir
pleuropneumonia
specif
variant
aspir
pneumonia
characterist
polymicrobi
promin
involv
anaerob
bacteria
disord
larg
volum
aspir
episod
usual
seizur
alcohol
stupor
occur
day
week
present
sign
symptom
pneumonia
aspir
bolu
usual
enrich
anaerob
microorgan
presenc
sever
gingiv
explain
fact
syndrom
rare
edentul
presenc
anaerob
often
result
lung
abscess
correspond
sever
pleural
reaction
rare
two
mechan
allow
microorgan
appear
alveolar
level
first
hematogen
spread
clearli
occur
tricuspid
endocard
bronchocentr
rather
vasocentr
patholog
bacteri
pneumonia
suggest
rare
even
immunocompromis
patient
site
infect
second
mechan
direct
spread
contigu
site
infect
infradiaphragmat
infect
primari
empyema
mechan
microorgan
reach
lower
respiratori
tract
import
implic
prevent
infect
control
diagnosi
pneumonia
rest
disproportion
presenc
infiltr
chest
radiograph
pneumonia
consid
patient
newli
acquir
respiratori
symptom
cough
sputum
product
dyspnea
chest
pain
especi
accompani
fever
auscultatori
find
abnorm
breath
sound
particularli
crackl
elderli
inadequ
immun
respons
pneumonia
may
present
nonrespiratori
symptom
delirium
fatigu
failur
thrive
worsen
underli
chronic
ill
fall
elderli
patient
fever
may
absent
tachypnea
usual
present
along
abnorm
physic
examin
chest
unfortun
none
symptom
uniqu
pneumonia
mani
symptom
clinic
sign
occur
lrti
henc
depend
abnorm
chest
radiograph
accur
diagnosi
unfortun
plain
chest
radiograph
reliabl
standard
base
diagnosi
signific
interand
intraobserv
variabl
exist
interpret
problem
particularli
acut
patient
suspect
ventilatorassoci
pneumonia
vap
multipl
radiograph
mimic
pneumonia
exist
also
simpli
chang
ventil
set
alter
radiograph
patient
underli
pulmonari
diseas
differenti
infecti
process
deterior
underli
pulmonari
diseas
also
often
difficult
occasion
patient
pneumonia
may
chest
radiograph
interpret
normal
falseneg
read
repres
subtl
find
overlook
routin
interpret
interpret
improv
obtain
standard
upright
posteroanterior
pa
later
view
whenev
possibl
use
sensit
techniqu
comput
tomographi
ct
often
detect
infiltr
occasion
sever
dehydr
lack
circul
neutrophil
prevent
radiograph
chang
pneumonia
underli
deficit
correct
despit
shortcom
radiograph
use
differenti
pneumonia
condit
may
clinic
mimic
moreov
radiograph
find
may
suggest
specif
etiolog
condit
includ
lung
abscess
tuberculosi
radiograph
also
identifi
coexist
condit
bronchial
obstruct
pleural
effus
may
help
evalu
sever
ill
identifi
multilobar
involv
diagnosi
pneumonia
actual
twostep
process
first
determin
pneumonia
inde
present
howev
optim
antimicrobi
manag
etiolog
diagnosi
also
need
demonstr
presenc
microorgan
cultur
stain
patholog
specimen
classic
method
demonstr
caus
agent
method
woefulli
inadequ
diagnos
pneumonia
reason
vari
depend
type
pneumonia
communityacquir
pneumonia
cap
mani
caus
microorgan
easili
grown
cultur
even
aggress
cultur
extens
use
diagnost
modal
etiolog
diagnosi
remain
unknown
major
case
contrast
nosocomi
pneumonia
especi
vap
high
incid
colon
frequent
result
mani
falseposit
cultur
polymicrobi
cultur
monomicrobi
pneumonia
chronic
pneumonia
tuberculosi
endem
fungal
diseas
slow
growth
characterist
delay
definit
microbiolog
diagnosi
week
net
result
antimicrobi
treatment
pneumonia
often
empir
clearli
new
nonculturebas
diagnost
method
need
lack
microbiolog
diagnosi
nonspecif
sign
symptom
radiograph
infiltr
lead
frequent
consider
pneumonia
differenti
diagnosi
mani
pulmonari
diseas
essenti
disord
caus
sign
symptom
inflamm
abnorm
radiograph
infiltr
mistaken
pneumonia
differenti
diagnosi
vari
somewhat
among
variou
cap
syndrom
tabl
list
mani
entiti
differenti
diagnosi
mean
exhaust
differenti
diagnosi
expand
prior
radiograph
clinic
inform
known
bronchiti
even
uri
mistaken
pneumonia
patient
previous
unknown
chronic
infiltr
common
combin
disord
also
mimic
pneumonia
exampl
congest
heart
failur
often
complic
influenza
patient
also
chronic
obstruct
pulmonari
diseas
copd
asymmetr
infiltr
may
seen
problem
worst
patient
suspect
vap
poor
radiograph
techniqu
multipl
caus
fever
leukocytosi
critic
ill
presenc
pneumonia
put
etiolog
often
assum
appropri
respons
antibiot
howev
mani
diseas
differenti
may
selflimit
respond
adjuv
therapi
pneumonia
therefor
fals
suggest
diagnosi
pneumonia
convers
cap
patient
case
vap
due
specif
etiolog
respond
even
specif
therapi
pneumonia
remain
common
seriou
ill
despit
avail
potent
antimicrobi
effect
vaccin
us
pneumonia
seventh
lead
caus
death
number
one
caus
death
infect
similar
annual
rate
approxim
case
per
probabl
case
develop
countri
howev
data
regard
incid
suboptim
pneumonia
notifi
diseas
us
data
reflect
combin
pneumonia
influenza
disproportion
high
number
case
cap
report
bia
data
death
due
diseas
may
also
mix
due
pneumonia
exampl
effect
antiretrovir
therapi
becam
avail
mani
death
human
immunodefici
viru
attribut
pneumonia
septicemia
becom
lead
caus
death
us
data
suggest
sourc
infect
approxim
septic
shock
patient
pneumonia
therefor
underreport
overreport
death
pneumonia
begin
twentieth
centuri
pneumonia
tuberculosi
lead
caus
death
us
develop
nation
death
heart
diseas
exceed
pneumonia
us
death
pneumonia
exceed
death
malign
death
pneumonia
rapidli
fall
even
effect
antibiot
discov
influenza
pandem
would
occasion
caus
signific
spike
pneumonia
mortal
fall
mortal
without
antibiot
repres
improv
sanit
public
health
measur
parallel
similar
decreas
tuberculosi
mortal
howev
effect
antimicrobi
therapi
becam
routin
avail
parallel
tuberculosi
disappear
effect
antitubercul
therapi
result
persist
progress
fall
mortal
rate
tuberculosi
longer
top
caus
death
ageadjust
mortal
rate
us
case
per
popul
contrast
initi
increas
slope
declin
pneumonia
mortal
ageadjust
mortal
pneumonia
us
reach
plateau
fallen
significantli
sinc
approxim
persist
mortal
suggest
adequ
antibiot
therapi
necessari
antibiot
alon
suffici
decreas
pneumonia
mortal
overal
incid
case
cap
approxim
per
person
per
year
howev
vari
consider
age
sex
race
socioeconom
condit
incid
cap
highest
among
oldest
youngest
member
popul
us
highest
incid
children
younger
year
age
case
per
person
per
year
similar
rate
report
older
individu
age
europ
case
per
person
per
year
pneumonia
account
nearli
half
death
result
infecti
diseas
geriatr
popul
death
respiratori
tract
infect
occur
person
older
year
howev
case
fatal
rate
increas
young
elderli
death
pneumococc
pneumonia
occur
patient
age
year
approxim
million
case
cap
estim
occur
annual
us
result
hospit
per
year
despit
frequenc
pneumonia
caus
acut
lrti
symptom
small
minor
patient
commun
one
prospect
studi
lrti
requir
antibiot
adult
seek
attent
physician
patient
found
pneumonia
major
patient
cap
treat
outpati
mortal
rate
less
patient
need
hospit
vari
wide
depend
characterist
healthcar
system
physician
prefer
incid
rang
european
north
american
studi
frequenc
admiss
patient
low
risk
death
variou
predict
model
vari
greatli
physician
gener
overestim
risk
die
cap
among
patient
pneumonia
suffici
sever
requir
admiss
hospit
report
mortal
rate
rang
high
increas
increas
age
gener
higher
mortal
rate
found
us
greater
use
outpati
treatment
aggress
treatment
termin
ill
patient
result
overal
sicker
popul
patient
admit
cap
admiss
intens
care
unit
icu
also
vari
dramat
countri
individu
hospit
gener
higher
percent
patient
cap
admit
icu
north
america
europ
hospit
area
limit
icu
resourcesb
much
higher
number
cap
patient
admit
icu
either
vasopressordepend
septic
shock
respiratori
failur
associ
mortal
invers
proport
number
admit
mainli
mortal
ventil
septic
shock
patient
much
greater
mortal
high
icu
nearli
patient
ventil
mortal
decreas
icu
less
half
patient
sever
cap
ventil
defin
hcap
new
entiti
complic
epidemiolog
cap
sinc
studi
distinguish
subgroup
would
classifi
patient
cap
clearli
recogn
distinct
usual
cap
extens
studi
hcap
publish
major
hcap
patient
nurs
home
chronic
care
facil
epidemiolog
studi
focus
group
pneumonia
patient
whether
type
hcap
exampl
patient
receiv
longterm
home
parenter
antibiot
chronic
hemodialysi
patient
similar
epidemiolog
nurs
home
patient
unclear
nurs
homeacquir
pneumonia
hap
common
form
hcap
pneumonia
highest
mortal
rate
nurs
homeacquir
infect
frequent
result
transfer
case
hospit
manag
overal
incid
nurs
homeacquir
pneumonia
vari
episod
per
day
resid
care
nosocomi
pneumonia
includ
hospitalacquir
ventilatorassoci
pneumonia
hospitalacquir
pneumonia
defin
pneumonia
occur
least
h
admiss
hospit
vap
defin
pneumonia
occur
h
intub
hospitalacquir
pneumonia
occur
per
hospit
patient
complic
cours
mani
patient
undergo
surgeri
incid
significantli
higher
patient
undergo
mechan
ventil
occur
patient
crude
rate
vap
rang
per
day
intub
mechan
ventil
cumul
incid
increas
rate
approxim
week
plateau
patient
undergo
longterm
mechan
ventil
substanti
lower
daili
attack
rate
among
nosocomi
infect
pneumonia
highest
morbid
mortal
mortal
patient
high
estim
differ
seri
one
third
one
half
hap
death
thought
due
infect
remaind
death
result
comorbid
diseas
contrast
set
vap
attribut
mortal
vap
averag
lower
studi
fact
author
estim
develop
vap
may
increas
mortal
correct
confound
factor
independ
influenc
mortal
attribut
mortal
vap
may
debat
develop
vap
consist
increas
length
stay
survivor
averag
day
per
patient
epidemiolog
type
pneumonia
well
defin
pneumonia
immunocompromis
patient
depend
type
immunocompromis
epidemiolog
cue
less
common
form
cap
list
tabl
inform
epidemiolog
type
pneumonia
specif
microorgan
found
elsewher
encyclopedia
etiolog
pneumonia
depend
sever
factor
includ
patient
immun
statu
ie
immunocompet
vs
immunocompromis
recent
antibiot
use
locat
patient
pneumonia
occur
commun
acquir
vs
nosocomi
tabl
howev
caus
spectrum
alway
includ
pathogen
frequent
associ
acut
cap
vap
patient
recent
admit
hospit
receiv
antibiot
mimic
spectrum
acut
cap
mani
pneumonia
immunocompromis
patient
also
caus
typic
cap
pathogen
two
factor
combin
shift
spectrum
away
typic
cap
worsen
immunocompromis
exposur
broadspectrum
antibiot
therapi
especi
prolong
exampl
former
human
immunodefici
viru
hiv
diseas
helper
tlymphocyt
count
cluster
determin
cellsmm
usual
cap
pathogen
tuberculosi
common
caus
pneumonia
count
fall
cellsmm
opportunist
infect
includ
pneumocysti
jerovecii
cmv
becom
common
exposur
broadspectrum
antibiot
enough
shift
spectrum
hcap
toward
nosocomi
pneumonia
etiolog
spectrum
pneumonia
continu
slowli
expand
roughli
everi
decad
new
pathogen
ad
spectrum
newli
recogn
pathogen
result
either
chang
host
immun
hiv
epidem
bone
marrowstem
cell
transplant
improv
diagnost
test
latter
advanc
medic
practic
often
provid
explan
previous
enigmat
case
pneumonia
mani
new
pathogen
first
recogn
conjunct
epidem
classic
exampl
legionnair
diseas
initi
wellpublic
epidem
led
identif
genu
multipl
speci
subsequ
defin
test
sampl
prior
epidem
random
case
retrospect
demonstr
import
legionella
spp
pneumonia
hantaviru
pulmonari
syndrom
recogn
approxim
decad
later
latest
exampl
sever
acut
respiratori
syndrom
sar
epidem
first
appear
southeastern
asia
late
sar
pathogen
subsequ
identifi
coronaviru
world
health
organ
laboratori
network
april
sar
coronaviru
sarscov
distantli
relat
previous
sequenc
coronavirus
believ
circul
human
previous
sarscov
postul
previous
unknown
anim
coronaviru
mutat
develop
abil
infect
human
high
transmiss
rate
especi
healthcar
set
household
suggest
littl
nativ
immun
viru
exist
previous
new
previous
unrecogn
pathogen
play
role
manag
decis
major
issu
pneumonia
appear
antibiot
resist
strain
known
common
bacteri
pathogen
emerg
antibioticresist
isol
truli
reach
epidem
proport
cap
vap
multidrugresist
pathogen
norm
vap
emerg
drugresist
streptococcu
pneumonia
drsp
increasingli
common
problem
worldwid
pneumococci
area
fall
categori
current
definit
controversi
exist
howev
clinic
relev
vitro
resist
absenc
mening
whether
new
therapeut
approach
requir
whether
resist
influenc
outcom
cap
resist
penicillin
present
often
vitro
resist
agent
methicillinresist
staphylococc
aureu
previous
thought
exclus
hap
pathogen
make
appear
caus
cap
common
denomin
develop
antibiot
resist
antibiot
usag
unfortun
develop
new
antimicrobi
slow
far
success
fight
rearguard
action
advanc
antibiot
resist
benefit
accru
shorten
cours
appropri
antibiot
use
suspect
vap
surgic
prophylaxi
howev
avoid
even
start
antibiot
nonbacteri
infect
outpati
viral
uri
strategi
like
slow
trend
contrast
bacteri
type
pneumonia
tubercul
p
jeroveci
lack
even
minim
effect
agent
issu
nonbacteri
pneumonia
aspergillu
nontubercul
mycobacteria
respiratori
syncyti
viru
rsv
cmv
sar
mani
viral
agent
cure
pneumonia
realli
depend
reconstitut
patient
immun
system
clearli
research
need
area
given
resist
issu
antibiot
lack
effect
treatment
type
pneumonia
immunomodulatori
treatment
increasingli
import
consider
treatment
pneumonia
immun
modul
take
three
pathway
one
develop
use
less
immunosuppress
treatment
malign
transplant
patient
import
advanc
area
alreadi
result
renal
transplant
patient
return
near
normal
respons
bacteri
pneumonia
infrequ
occurr
opportunist
pathogen
caus
pneumonia
second
rout
immun
childhood
immun
long
track
record
effect
prevent
respiratori
infect
pertussi
diphtheria
infect
seen
pathogen
develop
societi
vaccin
provid
recent
use
haemophilu
influenza
protein
conjug
pneumococc
vaccin
nearli
elimin
mening
bacteria
significantli
reduc
incid
respiratori
tract
infect
conjug
pneumococc
vaccin
decreas
infect
children
also
result
decreas
invas
infect
child
adult
caregiv
even
polysaccharid
pneumococc
vaccin
appear
decreas
rate
invas
diseas
even
decreas
overal
pneumonia
rate
third
immunomodulatori
strategi
specif
immunomodul
establish
infect
use
colonystimul
factor
filgrastim
sargramostim
neutropen
patient
one
exampl
recent
releas
drotrecogin
alfa
activ
activ
protein
c
sever
sepsi
offer
hope
improv
mortal
bacteri
cap
especi
pneumococc
cap
pneumonia
common
signific
problem
clinic
medicin
certain
aspect
pathogenesi
manag
common
form
pneumonia
signific
differ
also
exist
differ
discuss
articl
specif
differ
pneumonia
syndrom
pathogen
molecul
involv
host
immun
diseas
differenti
diagnosi
